TR200000805T2 - Antibakteriyel etki gösteren 3'-N degişimli 6-0 ikameli eritromisin ketolid türevleri. - Google Patents

Antibakteriyel etki gösteren 3'-N degişimli 6-0 ikameli eritromisin ketolid türevleri.

Info

Publication number
TR200000805T2
TR200000805T2 TR2000/00805T TR200000805T TR200000805T2 TR 200000805 T2 TR200000805 T2 TR 200000805T2 TR 2000/00805 T TR2000/00805 T TR 2000/00805T TR 200000805 T TR200000805 T TR 200000805T TR 200000805 T2 TR200000805 T2 TR 200000805T2
Authority
TR
Turkey
Prior art keywords
ketolid
erythromycin
derivatives
change
antibacterial effect
Prior art date
Application number
TR2000/00805T
Other languages
English (en)
Inventor
Sun Or Yat
Ma Zhenkun
T.Chu Daniel
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR200000805T2 publication Critical patent/TR200000805T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bulus antibakteriyel aktiviteye sahip 3'-N, ile degisiklige ugratilmis yeni 6-0 ikameli eritromisin ketolid bilesikleri ve bunlarin farmasötik olarak kabul edilebilir tuzlari ve esterleriyle, böyle bir bilesigin terapötik olarak etkili bir miktarini ve bir farmasötik olarak kabul edilebilir tasiyici madde içeren farmasötik bilesimlerle ve memelilerde bakteriyel enfeksiyonlarin tedavisi için bir yöntemle ilgili olup bu yöntem söz konusu memeliye yukarida açiklanan bir bilesigin terapötik olarak etkili bir miktarinin uygulanmasini içermektedir.
TR2000/00805T 1997-09-30 1998-09-16 Antibakteriyel etki gösteren 3'-N degişimli 6-0 ikameli eritromisin ketolid türevleri. TR200000805T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94087197A 1997-09-30 1997-09-30
US13312198A 1998-08-12 1998-08-12

Publications (1)

Publication Number Publication Date
TR200000805T2 true TR200000805T2 (tr) 2000-10-23

Family

ID=26831064

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00805T TR200000805T2 (tr) 1997-09-30 1998-09-16 Antibakteriyel etki gösteren 3'-N degişimli 6-0 ikameli eritromisin ketolid türevleri.

Country Status (22)

Country Link
EP (1) EP1025114B1 (tr)
JP (1) JP2001518476A (tr)
KR (1) KR20010030807A (tr)
CN (1) CN1271363A (tr)
AR (1) AR015727A1 (tr)
AT (1) ATE260293T1 (tr)
AU (1) AU737310B2 (tr)
BG (1) BG104340A (tr)
BR (1) BR9812577A (tr)
CA (1) CA2303930A1 (tr)
CO (1) CO4990958A1 (tr)
DE (1) DE69821964T2 (tr)
DK (1) DK1025114T3 (tr)
ES (1) ES2217579T3 (tr)
HU (1) HUP0004579A3 (tr)
IL (1) IL134608A0 (tr)
NO (1) NO20001439L (tr)
PL (1) PL339575A1 (tr)
PT (1) PT1025114E (tr)
SK (1) SK4562000A3 (tr)
TR (1) TR200000805T2 (tr)
WO (1) WO1999016779A1 (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
WO2002014339A1 (en) * 2000-08-14 2002-02-21 Taisho Pharmaceutical Co., Ltd. Process for producing erythromycin derivative
US20020111317A1 (en) * 2000-09-25 2002-08-15 Leonard Katz Sixteen-membered macrolide compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
CN108101948A (zh) * 2004-02-27 2018-06-01 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
EP1723159B1 (en) * 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
US20090170790A1 (en) * 2004-10-25 2009-07-02 Biswajit Das Ketolide derivatives as antibacterial agents
WO2006129257A2 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
EP1934237A2 (en) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
EP3290427A1 (en) 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
US20090005325A1 (en) * 2005-11-23 2009-01-01 Biswajit Bas Ketolide Derivatives as Antibacterial Agents
RU2455308C2 (ru) * 2006-05-01 2012-07-10 Тайсо Фармасьютикал Ко., Лтд. Макролидные производные
WO2008099368A1 (en) * 2007-02-15 2008-08-21 Ranbaxy Laboratories Limited Macrolide derivatives as antibacterial agents
WO2008111020A2 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Macrolide derivatives as antibacterial agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
ATE259823T1 (de) * 1995-11-08 2004-03-15 Abbott Lab Tricyclische erythromycinderivate

Also Published As

Publication number Publication date
CN1271363A (zh) 2000-10-25
IL134608A0 (en) 2001-04-30
AU9317698A (en) 1999-04-23
DE69821964T2 (de) 2004-12-30
BG104340A (en) 2001-01-31
PT1025114E (pt) 2004-07-30
ATE260293T1 (de) 2004-03-15
AR015727A1 (es) 2001-05-16
NO20001439L (no) 2000-05-29
HUP0004579A2 (hu) 2001-05-28
EP1025114A1 (en) 2000-08-09
CA2303930A1 (en) 1999-04-08
CO4990958A1 (es) 2000-12-26
DE69821964D1 (de) 2004-04-01
NO20001439D0 (no) 2000-03-20
WO1999016779A1 (en) 1999-04-08
ES2217579T3 (es) 2004-11-01
EP1025114B1 (en) 2004-02-25
BR9812577A (pt) 2000-10-17
KR20010030807A (ko) 2001-04-16
JP2001518476A (ja) 2001-10-16
HUP0004579A3 (en) 2001-11-28
AU737310B2 (en) 2001-08-16
PL339575A1 (en) 2000-12-18
DK1025114T3 (da) 2004-07-05
SK4562000A3 (en) 2000-09-12

Similar Documents

Publication Publication Date Title
TR200000805T2 (tr) Antibakteriyel etki gösteren 3'-N degişimli 6-0 ikameli eritromisin ketolid türevleri.
TR199901127T2 (tr) Antibakteriyel etkili 6-O-ikameli ketolitler.
TR200001140T2 (tr) 6, 11-Köprülü eritromisin türevleri.
BG104434A (en) 2-halo-6-o-substituted ketolide derivatives
TR200000620T2 (tr) 6.9-Köprülü eritromisin türevleri.
TR199902995T2 (tr) 9-Oksim eritromisin türevleri
CA2316919A1 (en) Novel macrolides
BR9714287A (pt) Antibiótico cristalino designado solvato 6-o-metileritromicina forma 0, solvato de 6-o-metileritromicina forma 0, composição, processos para tratamento de infecções bacterianas em um mamìfero hospedeiro com necessidade de tal tratamento e para preparação de solvato de 6-o-metileritomicina a forma 0, 6-o-metileritromicina forma 0--etanolato, suspensão para administração oral, e, complexo de solvato de 6-o-metileritromicina a forma 0-carbÈmero.
BR9714269A (pt) Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicos
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
FR2757522B1 (fr) Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
TR200101241T2 (tr) Yeni makrolit antibiyotikler
DE69631609D1 (en) Tricyclische erythromycinderivate
AP2001002142A0 (en) 13-membered azalides and their use as antibiotic agents.
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
MA26735A1 (fr) Formes cristallines nouvelles d'un antibiotique macrolide, procede pour leur preparation et compositions pharmaceutiques les contenant
TR199902820T2 (tr) Multisiklik eritromisin türevleri.
AR005136A1 (es) Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamento
IT1301967B1 (it) Derivato di eritromicina ad attivita' antibiotica
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.